Navigation Links
International Isotopes Inc. Announces Third Quarter And Nine Months 2013 Financial Results
Date:11/15/2013

erating expense are the result of management's continued efforts to reduce discretionary costs where possible and secure beneficial pricing on general operating purchases. Research and development expense incurred, with regard to the planning and construction of the proposed de-conversion facility we plan to build in New Mexico, decreased by approximately 48% and 29% for the three and nine months ended September 30, 2013, respectively, compared to the same periods in 2012.

Our net loss for the three months ended September 30, 2013 was $424,107, compared to $591,526 for the same period in 2012.  This is a decrease in loss of approximately 28%.  Our net loss for the nine-month period ended September 30, 2013, was $1,492,209 as compared to $1,696,905 for the same period in 2012.  This is a decrease in loss of approximately 12%.  The decrease in net loss is the result of the slight increase in gross profit percentage as well as a significant reduction in overall operating costs and expenses.

Steve T. Laflin, President and CEO of the Company said, "Despite the small decline in revenue seen this year we have been able to successfully control production costs and reduce operating expenses in order to improve gross profit and continue to move the Company towards profitability.  Part of that cost control involves placing additional engineering work and formal design activities for the planned Hobbs de-conversion facility on hold for the time being.
We are still confident that we will eventually be able to obtain contracts for additional de-conversion service and once we have fully committed the capacity of the facility under contract we will once again resume our search for financing the balance of the project and resume the schedule for design and construction.

"Delays in cobalt production activities and transfers have had the most detrimental
'/>"/>

SOURCE International Isotopes Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. New U.S. Patent Issued To Dyadic International
2. Quest International Appointed As Authorized Reseller For Sony Electronics Medical Systems Division
3. HeartWare International Reports $54.8 Million In Third Quarter 2013 Revenue; 140% Increase From Third Quarter Of 2012
4. SRI International Completes Biosciences Facility Expansion in Shenandoah Valley, Virginia
5. Biocartis Presents the Successful use of Idylla[TM] for the Detection of the BRAF Mutation Status in Tumour Samples at the International AACR Congress (American Association for Cancer Research) in Boston
6. 3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics
7. Dyadic International Extends All Debt Maturity Dates
8. Improving Outcomes in the Treatment and Management of Metastatic Colorectal Cancer - International White Paper Launched at European Cancer Congress 2013
9. Mylan Supports Generic Drug Industrys Call on FDA to Uphold Consistent, Proven International Standard for Biosimilar Naming
10. CIVCO Names Darrell Newcombe as Vice President of International Sales for Radiation Oncology
11. Paul Kauffman of Accident Fund to Present on Identifying Risky Opioid Prescribing Patterns at 99th Annual International Association of Industrial Accident Boards & Commissions Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... SILVER SPRING, Md. , Aug. 29, 2014 /PRNewswire/ ... today that the U.S. District Court for the District ... in its favor in the company,s case against Sandoz, ... opinion, Judge Peter Sheridan ruled that U.S. ... Sandoz, Inc., and enjoined Sandoz from marketing its generic ...
(Date:8/29/2014)... 2014 /PRNewswire-iReach/ -- ChemImage will present a workshop focused ... Zealand Forensic Science Society,s 22 nd International ... Adelaide, Australia .  Forensic Scientists will be ... hyperspectral imaging can bring to examination procedures. ... of Product Development at ChemImage, will host a ...
(Date:8/29/2014)... and MENLO PARK, Calif. , Aug. ... (OTCQB: DMPI) ("DelMar" "the Company") today announced the ... The Company recently changed its fiscal year end to ... list its common stock on a national securities exchange ... statements as filed with the United States Securities Exchange ...
Breaking Medicine Technology:District Court Decision Received In Remodulin Patent Case 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 2ChemImage to Discuss Hyperspectral Imaging for Forensic Investigation at the ANZFSS 22nd International Symposium on the Forensic Sciences 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 2DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 3DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 4DelMar Pharmaceuticals Fiscal 2014 Year End Results and Summary of Recent Developments 5
... 2011 Eli Lilly and Company (NYSE: ... signed agreements with private investors Care Capital and ... and privately-held biotechnology company. BioCritica, based in Central ... development and commercialization of Xigris® (drotrecogin alfa (activated)), ...
... ATLANTA, May 23, 2011 CardioMEMS, Inc ., ... is commercializing a proprietary wireless sensing and communication technology ... and CEO, Jay Yadav, M.D., was presented with a ... by the Atlanta Business Chronicle.  The award was conferred ...
Cached Medicine Technology:Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 2Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 3Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 4Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 5Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 6Lilly and Investor Group Form New Critical Care Company BioCritica, Sign Xigris License Agreement 7CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 2CardioMEMS Founder Dr. Jay Yadav Honored With Health-Care Heroes Award by the Atlanta Business Chronicle 3
(Date:8/29/2014)... Daily Gossip reveals in its Get Rid of Cold ... cold sores patient who suffered from this terrible health problem for ... to share her tips and advices, but also her experience with ... the Get Rid of Cold Sores Fast program says that she ... least 4 years outbreaks have become more frequent. , Ellie ...
(Date:8/29/2014)... (PRWEB) August 29, 2014 Cosmetic Town ... knowledge and authenticity of its doctors. Cosmetic Town ... the most renowned doctors in their field are chosen ... assure patients have a direct link to potentially hundreds ... doctors will be able to communicate through the site’s ...
(Date:8/29/2014)... FL (PRWEB) August 29, 2014 The ... anxiously awaited final rule (file code CMS–0052–P) today allowing ... using the 2011 Edition Certified EHR Technology (CEHRT) or ... Eligible Professionals (EPs) who have not been able to ... reporting period in 2014 can continue to use 2011 ...
(Date:8/29/2014)... August 29, 2014 Champion boxers Laila ... disease by appearing on the annual MDA Show of ... 31, 9/8c on ABC television stations across the country. ... current host of “All In, with Laila Ali," will ... Boy during the Muscular Dystrophy Association's nationally broadcast show. ...
(Date:8/29/2014)... August 29, 2014 As reported by WKMS.com ... Recovery , an Ohio municipal court drug has come up ... Fred Moses, who serves as the presiding judge in a ... makers to offer addicts a medicated treatment option that can ... the drug known as Vivitrol, which blocks receptors in the ...
Breaking Medicine News(10 mins):Health News:Get Rid of Cold Sores Fast Review Reveals Simple Way to Eliminate Cold Sores in 12 Hours 2Health News:Cosmetic Town Now Advocates for the Rights of Cosmetic Patients Using Novel Approach 2Health News:Quirk Healthcare Outlook on MU2 Delay Confirmation 2Health News:Champion Boxers Fight Back Against Muscle Disease 2Health News:Champion Boxers Fight Back Against Muscle Disease 3Health News:Ohio Judge Pushes for Addiction Recovery Tool 2Health News:Ohio Judge Pushes for Addiction Recovery Tool 3
... issue of Archives of Surgery,Individuals with diabetes appear to ... use more ventilator support and have more complications during ... 17 million Americans have diabetes, with one-third remaining undiagnosed, ... develop complications more frequently and do worse after an ...
... rare neurological disorder that causes hand movement without the person ... the action . ,The afflicted person may sometimes ... so, even to the point of having to use the ... new study identified the areas of the brain involved in ...
... of Archives of Surgery,the rate of cases of colitis ... more than doubled among patients hospitalized in the United ... more severe and associated with an increased mortality rate. ... percent to 3 percent of healthy adults and about ...
... from Saint Louis University School of Public Health has found ... ,Qiang John Fu, M.D., Ph.D conducted a study of twins ... also associated with conduct disorder, is why some people with ... to quit become depressed when they cant. ,Dr. ...
... more common in the United States between 1973 and 2002 ... Archives of Dermatology. The rates of the disease vary by ... occurs when certain cells of the lymph system (called T ... several types of lymphoma, according to background information in the ...
... or removal of the tonsils, none reported an ongoing ... . ,Together with the sense of smell ... taste contributes considerably to flavor perception during eating and ... enjoyment of foods and beverages, according to background information ...
Cached Medicine News:Health News:Diabetes may Lead to More Complications 2Health News:Alien Hand Syndrome Causes Random Hand Movement 2Health News:Colitis More Common in Hospitalized Patients 2Health News:Colitis More Common in Hospitalized Patients 3Health News:Colitis More Common in Hospitalized Patients 4Health News:Study Finds Genetic Link Between Smoking Addiction and Major Depression 2Health News:Cutaneous T-cell Lymphoma Shows Steady Increase 2Health News:Patients Undergoing Tonsillectomy Shows No Change of Taste 2
Our high quality therapeutic drug monitoring reagents, calibrators and controls are available for most chemistry analyzers. Reproducible and accurate results for your laboratory needs....
Revised Drug calibrator that replaces existing Drug calibrator - this product contains Lithium in addition to Digoxin, Phenobarbital, OPhenytoin, & Theophulline....
Liquichek Rheumatoid Factor Control is a liquid trilevel control designed to monitor rheumatoid factor testing procedures, including nephelometric and latex agglutination methods....
... BD Macro-Vue RPR (Rapid Plasma Reagin) ... Tests are nontreponemal testing procedures for ... in A Manual of Tests for ... manual are the most widely used ...
Medicine Products: